Lux Capital

Founded 2000
Founders Josh Wolfe Peter Hebert Rob Paull

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 331
Average round size
info
The average size of a deal this fund participated in
$35M
Portfolio companies 174
Rounds per year 15.76
Lead investments 44
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.35
Exits 34
Key employees 13
Stages of investment
Early Stage Venture
Late Stage Venture
Private Equity
Seed
Summary

Lux Capital is the famous VC, which was founded in 2000. The company was established in North America in United States. The main department of described VC is located in the New York.

When the investment is from Lux Capital the average startup value is 500 millions - 1 billion dollars. The fund is constantly included in 13-24 deals per year. Deals in the range of 10 - 50 millions dollars are the general things for fund. The top activity for fund was in 2017. Opposing the other organizations, this Lux Capital works on 21 percentage points less the average amount of lead investments. Considering the real fund results, this VC is 5 percentage points more often commits exit comparing to other organizations. The higher amount of exits for fund were in 2019.

The typical case for the fund is to invest in rounds with 6-7 participants. Despite the Lux Capital, startups are often financed by General Catalyst, GV, Union Square Ventures. The meaningful sponsors for the fund in investment in the same round are New Enterprise Associates, Montage Ventures, Dolby Family Ventures. In the next rounds fund is usually obtained by Venrock, Kleiner Perkins, Bill Gates.

The current fund was established by Josh Wolfe, Peter Hebert, Rob Paull. Besides them, we counted 13 critical employees of this fund in our database.

The fund has no exact preference in some founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Auris Health, Inc., Zoox, Desktop Metal. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most successful fund investment fields, there are Software, Health Care.

Read more

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

A-Alpha Bio

Biotechnology
Health Care
Product Design
$20M08 Sep 2021 Seattle, Washington, United States

Atavistik Bio

Biotechnology
$60M24 Aug 2021 Cambridge, Massachusetts, United States

Maven Clinic

Apps
Family
Health Care
Health Diagnostics
Personal Health
Women's
$110M17 Aug 2021 New York, New York, United States

Mahana Therapeutics

Information Technology
Internet
Medical
Therapeutics
$61M11 Aug 2021 San Francisco, California, United States

Ahana

Analytics
$20M02 Aug 2021 California, United States

DoNotPay

Consulting
Internet
Legal
Legal Tech
$10M01 Aug 2021 Utah, United States

HiHello

Apps
Banking
Credit Cards
Payments
Software
$7M30 Jul 2021 Palo Alto, California, United States

Traba

Local
Marketplace
Staffing Agency
$3M22 Jul 2021 Miami, Florida, United States

Varda

Aerospace
Manufacturing
Product Design
$42M21 Jul 2021 -
News
Atavistik Bio Announces $60 Million Series A Financing to Advance Genetically-Validated Targets in Metabolic Diseases and Cancer

– Atavistik Bio, a pre-clinical biotechnology company pioneering the identification of metabolite-protein interactions that have the potential to lead to the discovery and development of first-in-class drug candidates powered by distinct allosteric control mechanisms, announced that the closing of a $60 million Series A financing round.
– The financing was led by The Column Group and joined by Lux Capital, and Nextech Invest.
– The new financing will support development of Atavistik’s drug discovery platform, and future identification of select drug candidates based on deep knowledge of disease relevant pathways that have evolved over millions of years by nature to be allosterically regulated by metabolites.

Corporate spend management startup Ramp snags $300M

– Ramp announced that it closed a $300m series C funding tranche led by Founders Fund, with participation from Redpoint Ventures, Thrive Capital, D1 Capital Partners, Spark Capital, Coatue Management, Iconiq, Altimeter, Stripe, Lux Capital, A* Partners, and Definition Capital.
– Ramp provides virtual and physical cards that offer 1.5% cashback on purchases. Its management tools allows companies to control spend with multi-level rules, vendor spending limits, merchant blacklists, and approvals, as well as spending insights that combine expense reporting, accounting, and more.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Lux Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: